N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
We spoke with Nigel today and asked about the progress the company is making and shareholders question.
N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programs, N4 Pharma will seek to receive upfront payments, milestone payments and ultimately royalty payments once products reach the market.
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
Listen On
Also Listen
-
Zak Mir Speaks with Stafford Masie and Warren Wheatley of Africa Bitcoin Corporation
Zak Mir talks to Stafford Masie, Executive Chairman, and Warren Wheatley, CEO, A -
Zak Mir talks to Dr Kerim Sener, Managing Director of Ariana Resources Plc
Zak Mir talks to Dr Kerim Sener, Managing Director of Ariana Resources, in the w -
Zak Mir talks to Paul Mathieson, CEO of Amazing AI
Zak's Traders Cafe sat down with Paul Mathieson, CEO of Amazing AI, to unpack a -
Zak Mir talks to Charles Dickson, CEO of Roadside Real Estate
We spoke with Charles Dixon, CEO of Roadside Real Estate, to unpack the company'